Warning letter
Central Admixture Pharmacy Services, Inc.: warning letter of Mar 29, 2024
FDA warning letter 674736 · Division of Pharmaceutical Quality Operations I
Key facts
| Reference number | 674736 |
|---|---|
| Company | Central Admixture Pharmacy Services, Inc. |
| Subject | CGMP/Drug Products/Adulterated |
| Issue date | Mar 29, 2024 |
| Posted date | May 14, 2024 |
| Issuing office | Division of Pharmaceutical Quality Operations I |
| Product type | Drugs |
| CFR sections cited | 211.192, 200.10(b), 211.160(b), 210.1(b) |
| Inspection city | Allentown |
| Inspection ZIP | 18106 |
| Inspection start date | Feb 27, 2023 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: